Walleye Trading’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $990K | Buy |
+6,600
| New | +$718K | ﹤0.01% | 2298 |
|
|
2026
Q1 | – | Sell |
-55,000
| Closed | -$5.62M | – | 4335 |
|
|
2025
Q4 | $5.62M | Sell |
55,000
-14,000
| -20% | -$1.25M | 0.01% | 1224 |
|
|
2025
Q3 | $4.31M | Buy |
69,000
+28,300
| +70% | +$1.54M | 0.01% | 1329 |
|
|
2025
Q2 | $2.12M | Buy |
40,700
+40,200
| +8,040% | +$1.8M | ﹤0.01% | 1691 |
|
|
2025
Q1 | $21.3K | Sell |
500
-3,500
| -88% | -$151K | ﹤0.01% | 3781 |
|
|
2024
Q4 | $122K | Sell |
4,000
-12,000
| -75% | -$338K | ﹤0.01% | 3475 |
|
|
2024
Q3 | $367K | Buy |
16,000
+6,400
| +67% | +$181K | ﹤0.01% | 2708 |
|
|
2024
Q2 | $277K | Buy |
+9,600
| New | +$224K | ﹤0.01% | 2891 |
|
|
2024
Q1 | – | Sell |
-9,600
| Closed | -$260K | – | 4982 |
|
|
2023
Q4 | $260K | Buy |
9,600
+6,100
| +174% | +$160K | ﹤0.01% | 3601 |
|
|
2023
Q3 | $104K | Sell |
3,500
-1,400
| -29% | -$49.2K | ﹤0.01% | 3946 |
|
|
2023
Q2 | $175K | Sell |
4,900
-41,600
| -89% | -$1.19M | ﹤0.01% | 3496 |
|
|
2023
Q1 | $1.09M | Buy |
46,500
+37,400
| +411% | +$1.07M | ﹤0.01% | 2140 |
|
|
2022
Q4 | $248K | Sell |
9,100
-25,000
| -73% | -$1.14M | ﹤0.01% | 3409 |
|
|
2022
Q3 | $1.84M | Sell |
34,100
-4,200
| -11% | -$216K | 0.01% | 1755 |
|
|
2022
Q2 | $1.54M | Buy |
38,300
+13,000
| +51% | +$644K | 0.01% | 1877 |
|
|
2022
Q1 | $1.68M | Buy |
25,300
+21,700
| +603% | +$1.49M | 0.01% | 1807 |
|
|
2021
Q4 | $360K | Sell |
3,600
-2,500
| -41% | -$259K | ﹤0.01% | 3285 |
|
|
2021
Q3 | $763K | Sell |
6,100
-4,300
| -41% | -$511K | ﹤0.01% | 2499 |
|
|
2021
Q2 | $1.29M | Sell |
10,400
-3,100
| -23% | -$417K | 0.01% | 1884 |
|
|
2021
Q1 | $2.06M | Buy |
13,500
+8,100
| +150% | +$1.22M | 0.01% | 1299 |
|
|
2020
Q4 | $696K | Sell |
5,400
-17,800
| -77% | -$2.05M | ﹤0.01% | 2368 |
|
|
2020
Q3 | $2.59M | Sell |
23,200
-900
| -4% | -$82.3K | 0.01% | 952 |
|
|
2020
Q2 | $1.96M | Buy |
24,100
+22,800
| +1,754% | +$1.84M | 0.01% | 1117 |
|
|
2020
Q1 | $90K | Sell |
1,300
-31,500
| -96% | -$2.42M | ﹤0.01% | 3177 |
|
|
2019
Q4 | $2.56M | Buy |
32,800
+15,700
| +92% | +$1.13M | 0.02% | 1020 |
|
|
2019
Q3 | $1.09M | Buy |
17,100
+12,500
| +272% | +$1.1M | 0.01% | 1530 |
|
|
2019
Q2 | $397K | Buy |
+4,600
| New | +$351K | ﹤0.01% | 2377 |
|
Other funds holding GH
DTC
Walleye Trading's GH Position: Q1 2025 in Review
Walleye Trading sold out of Guardant Health (GH) in Q1 2025, closing a stake of 1,600 shares — an estimated $69K sold.
Walleye Trading first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $2.72M in Q1 2021. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.
- Walleye Trading reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
- Walleye Trading sold 1,600 Guardant Health shares in Q1 2025, an estimated $69K.
- Walleye Trading first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
- Walleye Trading's Guardant Health position peaked at $2.72M in Q1 2021.
- 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.
Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.